Trump confirms Makary out at FDA
President Donald Trump confirmed on Tuesday that Marty Makary would be leaving his post atop the U.S. Food and Drug Administration.
While speaking to reporters on the White House lawn Tuesday, Trump said Makary would be leaving. He said FDA deputy commissioner Kyle Diamantes will take over as the adminsitration seeks a new leader of the federal agency.
“He was having some difficulty,” Trump said. “Marty is a terrific guy, but he’s going to go and lead a good life.”
Trump did not specify what kind of difficulty Makary experienced. Several reports circulated that there was an internal dispute over approval for flavored vapes at the FDA. The Wall Street Journal reported that Trump pressured Makary to approve fruit-flavored vapes, but he was hesitant to do so.
Trump said many people are seeking the job atop the agency.
Makary was expected to testify on Capitol Hill Wednesday to present the FDA’s budget for the upcoming fiscal year. Diamantes is expected to take his place.
Makary was confirmed to lead the FDA in March 2025. Since then, he’s sought to make several changes to the agency’s policies and change organizational structure. Makary sought to limit antidepressants for pregnant women and ban kratom byproducts.
“He’s a friend of mine, he’s a wonderful man and he’s going to be off,” Trump said of Makary.
Latest News Stories
Manhattan Board Approves Kubota RTV Purchase for Sidewalk Plowing
Hegseth promises to fix barracks, but work could take time
‘Long overdue’: Praise for HHS’ action to bar taxpayer-funded sex-change procedures
Gas prices drop, but taxes make Illinois pricier than Midwest neighbors
Liquor License Amendments Approved for Frankfort, Joliet, and Lockport Businesses
Meeting Summary and Briefs: Will County Planning and Zoning Commission for December 16, 2025
Joliet Property Owner Cleared to Convert Non-Conforming Building into Two-Unit Residence
Colorado adopts first-of-its-kind water protections in U.S.
Epstein files redactions frustrate lawmakers
Supreme Court weighs gun owners’ challenge to IL transit carry ban
Nine pharmaceutical companies agree to most-favored-nation pricing
Congress leaves for holidays after zero progress on federal funding